This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Baylor College of Medicine, Duke University. Active years: 2008-2024.
Location History:
- Houston, TX (US) (2008 - 2017)
- Durham, NC (US) (2019 - 2023)
Company Filing History:
Years Active: 2008-2024
Title: Brent Hanks: Innovator in Cancer Treatment
Introduction
Brent Hanks is a notable inventor based in Houston, TX (US), recognized for his contributions to cancer treatment. He holds 8 patents that focus on innovative methods and compositions aimed at improving cancer therapies. His work has significantly impacted the field of immunotherapy, providing new avenues for treatment.
Latest Patents
Among his latest patents are "Methods of treatment of specific cancers with NLRP3 inhibitors and anti-PD1/PD-L1 antibodies." This patent outlines compositions and methods designed to enhance the efficacy of anti-PD-1/PD-L1 antibody immunotherapy in patients. Additionally, he has developed "Predictive biomarkers for cancer immunotherapy and methods of using same," which provides methods for detecting wnt-β-catenin-mediated cancers and those resistant to immunotherapy.
Career Highlights
Brent Hanks has had a distinguished career, working with prestigious institutions such as Baylor College of Medicine and Duke University. His research has been pivotal in advancing cancer treatment methodologies, particularly in the realm of immunotherapy.
Collaborations
Brent has collaborated with notable colleagues, including David Spencer and Kevin Slawin, contributing to a rich exchange of ideas and innovations in cancer research.
Conclusion
Brent Hanks stands out as a significant figure in the field of cancer treatment, with a focus on innovative therapies that leverage immunotherapy. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.